Erlotinib Completed Phase 1 Trials for Breast Cancer Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 1 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT01650506 | Study of Erlotinib and Metformin in Triple Negative Breast Cancer | |
NCT00574366 | Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer |